New test available to detect anthrax
Emergency Management Alert, June 22, 2004
The Food and Drug Administration approved the first test for detecting antibodies to anthrax last week, the Centers for Disease Control and Prevention (CDC) announced.
The Anthrax Quick ELISA test, produced by Immunetics Inc. of Boston and funded by CDC, provides an easy-to-use clinical laboratory tool for assessing whether anthrax infections are in patients. State and private laboratories will begin using the new test shortly, the CDC said.
In the past, few laboratories other than the CDC and U.S. Army tested blood for anthrax.
It takes less than an hour to complete the new test, compared to previous testing methods that took up to four hours.
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Answering service messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- Q&A: Coding for dry skin due to cold weather
- Are your workforce members texting PHI?
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- Catch up on what's new with injections and infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- HIPAA Q&A: Answering service messages
- Q&A: Coding for sepsis when other conditions are present
- Are your workforce members texting PHI?
- HIPAA Q&A: TPO disclosures to a business associate
- Q&A: Coding for dry skin due to cold weather
- What does case-mix index mean to you?
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- Searched
